High-throughput screening of 11β-hydroxysteroid dehydrogenase type 1 scintillation proximity assay format

Assay and Drug Development Technologies

Volumn 3, Issue 4, 2005, Pages 377-384

  Solly, Kelli ^a   Mundt, Steven S ^a   Zokian, Hratch J ^a   Ding, Gloria Juy Fang ^a   Hermanowski Vosatka, Anne ^a   Strulovici, Berta ^a   Zheng, Wei ^a,b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTISONE; ENZYME INHIBITOR; GLUCOCORTICOID; HYDROCORTISONE;

ADIPOSE TISSUE CELL; ANIMAL CELL; ARTICLE; CHO CELL; DIABETES MELLITUS; DRUG DETERMINATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; HYPERLIPIDEMIA; LIVER CELL; NONHUMAN; OBESITY; PROTEIN TARGETING; SCINTILLATION; SEPARATION TECHNIQUE; THIN LAYER CHROMATOGRAPHY;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ANIMALS; ANTIBODIES, MONOCLONAL; CHO CELLS; COMBINATORIAL CHEMISTRY TECHNIQUES; CRICETINAE; CRICETULUS; ENZYME INHIBITORS; HUMANS; HYDROCORTISONE; MICROSOMES; SCINTILLATION COUNTING; TRANSFECTION; TRITIUM;

EID: 27144542109     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/adt.2005.3.377     Document Type: Article

References (15)

1. Seckl JR, Walker BR: 11β-Hydroxysteroid dehydrogenase type 1 - a tissue-specific amplifier of glucocorticoid action. Endocrinology 2001;142;1371-1376.
2. Blum A, Maser E: Enzymology and molecular biology of glucocorticoid metabolism in humans. Prog Nucleic Acids Res Mol Biol 2003;75:173-216.
3. Agarwal AK, Monder C, Eckstein B, White PC: Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase. J Biol Chem 1989;264:18939-18943.
4. Albiston AL, Obeysekere VR, Smith RE, Krozowski ZS: Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 1994;105:R11-R17.
5. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, Best R, Brown R, Edwards CR, Seckl JR, Mullins JJ: 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci U S A 1997;94(26):14924-14929.
6. Morton NM, Holmes MC, Fievet C, Staels B, Tailleux A, Mullins JJ, Seckl JR: Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11β-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem 2001;276:41293-41300
7. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS: A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;249:2166-2170.
8. Masazuki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, Shinyama H, Sharp MG, Fleming S, Mullins JJ, Seckl JR, Flier JS: Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 2003;112:83-90.
9. Alberts P, Nilsson C, Selen G, Engblom LO, Edling NH, Norling S, Klingstrom G, Larsson C, Forsgren M, Ashkzari M, Nilsson CE, Fiedler M, Bergqvist E, Ohman B, Bjork-strand E, Abrahmsen LB: Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 2003;144:4755-4762.
10. Andrews RC, Rooyackers O, Walker BR: Effects of the 11β-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. J Clin Endocrinol Metab 2003;88:285-291.
11. Maser E, Volker B, Friebertshauser J: 11β-Hydroxysteroid dehydrogenase type 1 from human liver: Dimerization and enzyme cooperativity support its postulated role as glucocorticoid reductase. Biochemistry 2002;41:2459-2465.
12. Schweizer RAS, Atanasov AG, Frey BM, Odermatt A: A rapid screening assay for inhibitors of 11β-hydroxysteroid dehydrogenases (11β-HSD): flavanone selectively inhibits 11β-HSD1 reductase activity. Mol Cell Endocrinol 2003; 212:41-49.
13. Mundt S, Solly K, Thieringer R, Hermanowski-Vosatka A: Development and application of a scintillation proximity assay for identification of selective inhibitors of 11β-hydroxysteroid dehydrogenase. Assay Drug Dev Technol 2005;3:367-375.
14. Olson S, Aster SD, Brown K, Carbin L, Graham DW, Hermanowski-Vosatka A, LeGrand CB, Mundt S, Robbins MA, Schaeffer JM, Slossberg LH, Szymonifka MJ, Thieringer R, Wright SD, Balkovec JM: Adamantyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1. Bioorg Med Chem Lett 2005 (in press).
15. Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73.